Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-06-02 Sale | 2022-06-03 4:13 pm | GENOCEA BIOSCIENCES INC. | GNCA | Duvall Diantha CHIEF FINANCIAL OFFICER | 1,355 | $0.06 | $81 | 75,388 (Direct) | View |
| 2022-05-26 Sale | 2022-05-26 4:11 pm | GENOCEA BIOSCIENCES INC. | GNCA | Duvall Diantha CHIEF FINANCIAL OFFICER | 24,407 | $0.0765 | $1,867 | 76,743 (Direct) | View |
| 2022-04-04 Sale | 2022-04-05 08:17 am | GENOCEA BIOSCIENCES INC. | GNCA | Duvall Diantha CHIEF FINANCIAL OFFICER | 963 | $1.25 | $1,204 | 91,775 (Direct) | View |
| 2022-03-16 Sale | 2022-03-17 4:11 pm | GENOCEA BIOSCIENCES INC. | GNCA | Duvall Diantha CHIEF FINANCIAL OFFICER | 2,873 | $1.1 | $3,160 | 205,238 (Direct) | View |
| 2021-04-02 Sale | 2022-03-16 5:31 pm | GENOCEA BIOSCIENCES INC. | GNCA | Duvall Diantha CHIEF FINANCIAL OFFICER | 1,436 | $2.5392 | $3,646 | 62,486 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-01-20 Option Award | 2023-01-24 4:10 pm | N/A 2033-01-19 | CURIS INC | CRIS | Duvall Diantha CFO | 500,000 | $0 | 500,000 (Direct) | View |
Ownership | 2022-08-10 4:00 pm | N/A 2032-07-25 | CURIS INC | CRIS | Duvall Diantha CFO | 0 | $0 | 540,000 (Direct) | View |
| 2022-03-15 Option Award | 2022-03-17 4:11 pm | N/A 2032-03-15 | GENOCEA BIOSCIENCES INC. | GNCA | Duvall Diantha CHIEF FINANCIAL OFFICER | 150,000 | $0 | 205,238 (Direct) | View |
| 2021-03-15 Option Award | 2021-03-17 1:59 pm | N/A 2031-03-15 | GENOCEA BIOSCIENCES INC. | GNCA | Duvall Diantha CHIEF FINANCIAL OFFICER | 250,000 | $0 | 250,000 (Direct) | View |
| 2020-06-01 Option Award | 2020-06-02 4:19 pm | N/A 2030-06-01 | GENOCEA BIOSCIENCES INC. | GNCA | Duvall Diantha CHIEF FINANCIAL OFFICER | 31,561 | $0 | 31,561 (Direct) | View |
| 2020-04-02 Option Award | 2020-04-06 4:06 pm | N/A 2030-04-02 | GENOCEA BIOSCIENCES INC. | GNCA | Duvall Diantha CHIEF FINANCIAL OFFICER | 58,612 | $0 | 58,612 (Direct) | View |